The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Age-related macular degeneration in individuals with clonal hematopoiesis.
 
Keishla Arce-Ruiz
No Relationships to Disclose
 
Lachelle Weeks
Consulting or Advisory Role - Abbvie
(OPTIONAL) Uncompensated Relationships - Cyclomics BV
 
Caitlyn Vlasschaert
No Relationships to Disclose
 
Shai Shimony
No Relationships to Disclose
 
Yating Wang
No Relationships to Disclose
 
Md Mesbah Uddin
No Relationships to Disclose
 
Pradeep Natarajan
Employment - Vertex (I)
Stock and Other Ownership Interests - Bolt Biotherapeutics; Candela; Mercury; Parameter Health; Preciseli; TenSixteen Bio; Vertex (I)
Consulting or Advisory Role - Allelica; Apple; AstraZeneca; Bain Capital; Blackstone; Bristol-Myers Squibb; crispr therapeutics; Esperion Therapeutics; Foresite Capital; Foresite Capital; Foresite Capital; Genentech/Roche; GV; HeartFlow; Lilly; Magnet Biomedicine; Novartis; Novo Nordisk; TenSixteen Bio; Tourmaline Bio
Research Funding - AstraZeneca; Genentech; Novartis
 
Alexander Bick
Consulting or Advisory Role - TenSixteen Bio
 
Benjamin Ebert
Stock and Other Ownership Interests - Exo Therapeutics; Neomorph; Skyhawk Therapeutics; TenSixteen Bio
Consulting or Advisory Role - Abbvie; Exo Therapeutics; Neomorph; Skyhawk Therapeutics; TenSixteen Bio
Research Funding - Calico (Inst); Celgene (Inst); Deerfield Management (Inst); Novartis Institutes for BioMedical Research (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to the prediction of risk of cardiovascular disease. (Inst)
 
Demetrios Vavvas
Honoraria - Genentech/Roche
Consulting or Advisory Role - OLIX/Sumitomo
Research Funding - OLIX/Sumitomo
Patents, Royalties, Other Intellectual Property - OVIVA
Expert Testimony - Roche
Travel, Accommodations, Expenses - Roche/Sumitomo